Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 6-K

Alterity Therapeutics Ltd

SEC Filing

Filed Sep 23, 2026Accepted Sep 23, 2026, 6:02 AM EDTCIK 1131343Accession 0001437749-26-030992
Share

Company context

Current securities

Recent company filings

  1. S-8 filingSep 18, 2026
  2. 6-K filingSep 18, 2026
  3. 6-K filingSep 16, 2026
  4. 6-K filingSep 8, 2026
  5. 6-K filingSep 8, 2026

As-filed source

Primary evidence